Tasosartan
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Tasosartan is an angiotensin II receptor antagonist.
It was withdrawn from FDA review by the manufacturer after phase III clinical trials showed elevated transaminases (a sign of possible liver toxicity) in a significant number of participants given the drug.[1][2]
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
Template:Agents acting on the renin-angiotensin system Template:Angiotensin receptor modulators